Cite
HARVARD Citation
Fleseriu, M. et al. (2022). Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension. European journal of endocrinology. 187 (4), pp. 531-541. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fleseriu, M. et al. (2022). Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension. European journal of endocrinology. 187 (4), pp. 531-541. [Online].